Palantir a high-risk investment with ’a one-of-a-kind growth and margin model’
LONDON - Itaconix PLC (LSE:ITX), a UK-based specialty chemicals company, announced on Tuesday that Maven Capital Partners (WA:CPAP) UK LLP has retained its 5.816% stake in the company. The notification follows a name change of the shareholder from Amati AIM VCT plc to Maven Renovar VCT PLC, which occurred after Maven Capital Partners took over as Investment Manager from Amati Global Investors.
The threshold crossing, which triggered the regulatory notification, took place on May 1, 2025, and the company was formally notified today, May 6, 2025. According to the disclosure, Maven Renovar VCT PLC holds 784,313 voting rights in Itaconix, representing the same percentage of total voting rights. No financial instruments were listed as part of the holding, indicating that the entire position is through direct share ownership.
The disclosure, required under the UK’s Disclosure and Transparency Rules (DTR), was made to provide transparency over the holdings of major shareholders in public companies. The rules stipulate that changes in significant shareholdings must be reported to ensure investors and the market are informed about who has potential influence over the company.
Itaconix has emphasized that there has been no change in the actual shareholding by Maven Renovar VCT PLC, with the notification being a formal requirement to report the change in the shareholder’s name only. The company’s shares are traded on the London Stock Exchange (LON:LSEG), and Itaconix specializes in creating sustainable ingredients for a wide range of consumer products.
The announcement was made in Glasgow and has been disseminated by RNS, the news service of the London Stock Exchange. It is based on a press release statement from Itaconix PLC and provides investors and the public with the latest shareholding structure of the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.